市場調査レポート

商品コード

1762250

軟部肉腫治療の世界市場：市場規模・シェア・動向、業界分析 (治療法別・適応症別・流通チャネル別・最終用途別・地域別)、将来予測 (2025年～2034年)

Soft Tissue Sarcoma Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment, Indication, Distribution Channel, End Use, and Region - Market Forecast, 2025-2034

出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 625,132円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 772,222円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 919,312円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.09円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、軟部肉腫治療の市場規模は2034年までに39億1,015万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

軟部肉腫治療市場は、筋肉、脂肪、血管、神経、結合組織に影響を及ぼす希少がんのグループである軟部肉腫を管理するために使用される治療に焦点を当てています。がんの罹患率の増加、標的療法や免疫療法の進歩、研究開発活動の活発化が軟部肉腫治療市場の成長を後押ししています。規制当局の承認と臨床試験の拡大が新規治療オプションの導入を促進し、患者の転帰を改善しています。精密医療、人工知能に基づく診断、新興市場における治療アクセスの拡大などに治療機会があります。併用療法、戦略的提携、外来治療モデルなどの動向は、市場全体の拡大にさらに貢献しています。

軟部肉腫治療市場：分析概要

治療法に基づくと、従来の化学療法に比べて有効性が向上し、副作用が軽減されることから、標的療法分野が軟部肉腫治療市場の収益で最大のシェアを占めています。血管新生阻害薬は、現在進行中の調査や規制当局による承認の増加により、最も急速な成長を遂げています。

局所性軟部肉腫は、早期に診断されることが多く、手術や放射線による治療が効果的であることから、適応症別では最大の市場シェアを占めています。転移性肉腫は、症例の増加と高度な治療オプションの需要により、最も急成長しているセグメントです。

流通チャネル別では、デジタル化の進展と宅配サービスの利便性からオンライン薬局の成長率が最も高いです。

最終用途に基づくと、総合的ながん治療を提供する一次治療センターとしての役割を果たす病院分野が最大のシェアを占めています。在宅治療は、在宅治療オプションへの嗜好の高まりとドラッグデリバリー方法の進歩により、最も急成長している分野です。

北米は、高い医療費、先進的な治療法、強力な規制支援により、軟部肉腫治療市場シェアを独占しています。アジア太平洋は最も急成長している市場であり、医療インフラの改善、認知度の向上、先進治療の採用増加などがその要因です。

注目すべき企業としては、Amgen Inc.、AstraZeneca plc、Bayer AG、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche AG、GlaxoSmithKline plc、Johnson &Johnson Services, Inc.、Merck &Co.、Novartis AG、Pfizer Inc.、Sanofiなどが挙げられます。

主な分析結果
イントロダクション
- 軟部肉腫治療市場の分析：地域別 (2020～2034年)
北米
- 北米：治療法別（2020～2034年）
- 北米：適応症別（2020～2034年）
- 北米：最終用途別（2020～2034年）
- 北米：流通チャネル別（2020～2034年）
- 米国
- カナダ
欧州
- 欧州：治療法別（2020～2034年）
- 欧州：適応症別（2020～2034年）
- 欧州：最終用途別（2020～2034年）
- 欧州：流通チャネル別（2020～2034年）
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：治療法別（2020～2034年）
- アジア太平洋：適応症別（2020～2034年）
- アジア太平洋：最終用途別（2020～2034年）
- アジア太平洋：流通チャネル別（2020～2034年）
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：治療法別（2020～2034年）
- 中東・アフリカ：適応症別（2020～2034年）
- 中東・アフリカ：最終用途別（2020～2034年）
- 中東・アフリカ：流通チャネル別（2020～2034年）
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東とアフリカ
ラテンアメリカ
- ラテンアメリカ：治療法別、2020-2034年
- ラテンアメリカ：適応症別（2020～2034年）
- ラテンアメリカ：最終用途別（2020～2034年）
- ラテンアメリカ：流通チャネル別（2020～2034年）
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第10章競合情勢

事業拡大・企業買収の分析
- 事業拡大
- 企業買収
提携/協業/合意/公開

第11章企業プロファイル

Amgen Inc.
AstraZeneca plc
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Merck & Co., Inc.

図表

List of Tables:

Table 1 Global Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 2 Global Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 3 Global Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 4 Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 5 North America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 6 North America: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 7 North America: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 8 North America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 9 U.S.: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 10 U.S.: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 11 U.S.: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 12 U.S.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 13 Canada: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 14 Canada: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 15 Canada: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 16 Canada: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 17 Europe: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 18 Europe: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 19 Europe: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 20 Europe: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 21 UK: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 22 UK: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 23 UK: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 24 UK: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 25 France: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 26 France: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 27 France: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 28 France: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 29 Germany: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 30 Germany: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 31 Germany: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 32 Germany: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 33 Italy: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 34 Italy: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 35 Italy: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 36 Italy: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 37 Spain: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 38 Spain: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 39 Spain: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 40 Spain: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 41 Netherlands: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 42 Netherlands: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 43 Netherlands: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 44 Netherlands: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 45 Russia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 46 Russia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 47 Russia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 48 Russia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 49 Rest of Europe: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 50 Rest of Europe: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 51 Rest of Europe: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 52 Rest of Europe: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 53 Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 54 Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 55 Asia Pacific: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 56 Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 57 China: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 58 China: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 59 China: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 60 China: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 61 India: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 62 India: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 63 India: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 64 India: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 65 Malaysia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 66 Malaysia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 67 Malaysia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 68 Malaysia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 69 Japan: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 70 Japan: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 71 Japan: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 72 Japan: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 73 Indonesia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 74 Indonesia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 75 Indonesia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 76 Indonesia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 77 South Korea: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 78 South Korea: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 79 South Korea: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 80 South Korea: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 81 Australia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 82 Australia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 83 Australia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 84 Australia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 85 Rest of Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 86 Rest of Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 87 Rest of Asia Pacific: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 88 Rest of Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 89 Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 90 Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 91 Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 92 Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 93 Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 94 Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 95 Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 96 Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 97 UAE: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 98 UAE: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 99 UAE: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 100 UAE: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 101 Israel: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 102 Israel: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 103 Israel: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 104 Israel: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 105 South Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 106 South Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 107 South Africa: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 108 South Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 109 Rest of Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 110 Rest of Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 111 Rest of Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 112 Rest of Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 113 Latin America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 114 Latin America: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 115 Latin America: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 116 Latin America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 117 Mexico: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 118 Mexico: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 119 Mexico: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 120 Mexico: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 121 Brazil: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 122 Brazil: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 123 Brazil: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 124 Brazil: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 125 Argentina: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 126 Argentina: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 127 Argentina: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 128 Argentina: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 129 Rest of Latin America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
Table 130 Rest of Latin America: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
Table 131 Rest of Latin America: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
Table 132 Rest of Latin America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global Soft Tissue Sarcoma Treatment Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Treatment
Figure 7. Global Soft Tissue Sarcoma Treatment Market, by Treatment, 2024 & 2034 (USD Million)
Figure 8. Market by Indication
Figure 9. Global Soft Tissue Sarcoma Treatment Market, by Indication, 2024 & 2034 (USD Million)
Figure 10. Market by End-Use
Figure 11. Global Soft Tissue Sarcoma Treatment Market, by End-Use, 2024 & 2034 (USD Million)
Figure 12. Market by Distribution Channel
Figure 13. Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2024 & 2034 (USD Million)

Product Code: PM1620

The soft tissue sarcoma treatment market size is expected to reach USD 3,910.15 million by 2034, according to a new study by Polaris Market Research. The report "Soft Tissue Sarcoma Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Targeted Therapy, Anti-angiogenesis Drugs, and Radiation Therapy), Indication, Distribution Channel, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The soft tissue sarcoma treatment market focuses on therapies used to manage soft tissue sarcomas, a group of rare cancers affecting muscles, fat, blood vessels, nerves, and connective tissues. The increasing incidence rates of cancer, advancements in targeted therapy and immunotherapy, and rising research and development activities propel the soft tissue sarcoma treatment market growth. Regulatory approvals and expanding clinical trials are driving the introduction of novel treatment options, improving patient outcomes. Opportunities lie in precision medicine, artificial intelligence-based diagnostics, and the expansion of treatment accessibility in emerging markets. Trends such as combination therapies, strategic collaborations, and outpatient treatment models are further contributing to the overall market expansion.

Soft Tissue Sarcoma Treatment Market Report Highlights

Based on treatment, the targeted therapy segment holds the largest share of the soft tissue sarcoma treatment market revenue due to its improved efficacy and reduced side effects compared to traditional chemotherapy. Anti-angiogenesis drugs are witnessing the fastest growth, driven by ongoing research and increasing regulatory approvals.

The localized soft tissue sarcoma segment, by indication, accounts for the largest market share as it is often diagnosed early and treated effectively with surgery and radiation. Metastatic sarcoma is the fastest-growing segment due to increasing cases and the demand for advanced treatment options.

Based on distribution channel, the online pharmacies segment is growing at the highest rate due to increasing digitalization and the convenience of home delivery services.

The hospitals segment, based on end use, holds the largest share as they serve as primary treatment centers offering comprehensive cancer care. Homecare is the fastest-growing segment due to the rising preference for at-home treatment options and advancements in drug delivery methods.

North America dominates the soft tissue sarcoma treatment market share due to high healthcare expenditure, advanced treatment availability, and strong regulatory support. Asia Pacific is the fastest-growing market, driven by improving healthcare infrastructure, rising awareness, and increasing adoption of advanced therapies.

A few notable market players are Amgen Inc.; AstraZeneca plc; Bayer AG; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline plc; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi.

Polaris Market Research has segmented the soft tissue sarcoma treatment market report on the basis of treatment, indication, distribution channel, end use, and region:

By Treatment Outlook (Revenue - USD Million, 2020-2034)

Chemotherapy

Targeted Therapy

Anti-angiogenesis Drugs

Radiation Therapy

By Indication Outlook (Revenue - USD Million, 2020-2034)

Regional

Local

Metastatic Sarcoma

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

Online Pharmacy

Retail Pharmacy

Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals

Homecare

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Soft Tissue Sarcoma Treatment Market Insights

4.1. Soft Tissue Sarcoma Treatment Market - Market Snapshot
4.2. Soft Tissue Sarcoma Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in Targeted Therapies
  - 4.2.1.2. Increasing Healthcare Expenditure
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Limited research funding
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Soft Tissue Sarcoma Treatment Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Soft Tissue Sarcoma Treatment Market, by Treatment

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
5.3. Chemotherapy
- 5.3.1. Global Soft Tissue Sarcoma Treatment Market, by Chemotherapy, by Region, 2020-2034 (USD Million)
5.4. Targeted Therapy
- 5.4.1. Global Soft Tissue Sarcoma Treatment Market, by Targeted Therapy, by Region, 2020-2034 (USD Million)
5.5. Anti-angiogenesis Drugs
- 5.5.1. Global Soft Tissue Sarcoma Treatment Market, by Anti-angiogenesis Drugs, by Region, 2020-2034 (USD Million)
5.6. Radiation Therapy
- 5.6.1. Global Soft Tissue Sarcoma Treatment Market, by Radiation Therapy, by Region, 2020-2034 (USD Million)

6. Global Soft Tissue Sarcoma Treatment Market, by Indication

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
6.3. Regional
- 6.3.1. Global Soft Tissue Sarcoma Treatment Market, by Regional, by Region, 2020-2034 (USD Million)
6.4. Local
- 6.4.1. Global Soft Tissue Sarcoma Treatment Market, by Local, by Region, 2020-2034 (USD Million)
6.5. Metastatic Sarcoma
- 6.5.1. Global Soft Tissue Sarcoma Treatment Market, by Metastatic Sarcoma, by Region, 2020-2034 (USD Million)

7. Global Soft Tissue Sarcoma Treatment Market, by End-Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
7.3. Hospitals
- 7.3.1. Global Soft Tissue Sarcoma Treatment Market, by Hospitals, by Region, 2020-2034 (USD Million)
7.4. Homecare
- 7.4.1. Global Soft Tissue Sarcoma Treatment Market, by Homecare, by Region, 2020-2034 (USD Million)
7.5. Others
- 7.5.1. Global Soft Tissue Sarcoma Treatment Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
8.3. Online Pharmacy
- 8.3.1. Global Soft Tissue Sarcoma Treatment Market, by Online Pharmacy, by Region, 2020-2034 (USD Million)
8.4. Retail Pharmacy
- 8.4.1. Global Soft Tissue Sarcoma Treatment Market, by Retail Pharmacy, by Region, 2020-2034 (USD Million)
8.5. Others
- 8.5.1. Global Soft Tissue Sarcoma Treatment Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Soft Tissue Sarcoma Treatment Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Soft Tissue Sarcoma Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
9.3. Soft Tissue Sarcoma Treatment Market - North America
- 9.3.1. North America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
- 9.3.2. North America: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
- 9.3.3. North America: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
- 9.3.4. North America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.5. Soft Tissue Sarcoma Treatment Market - US
  - 9.3.5.1. US: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.3.5.2. US: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.3.5.3. US: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.3.5.4. US: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.6. Soft Tissue Sarcoma Treatment Market - Canada
  - 9.3.6.1. Canada: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.3.6.2. Canada: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.3.6.3. Canada: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.3.6.4. Canada: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
9.4. Soft Tissue Sarcoma Treatment Market - Europe
- 9.4.1. Europe: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
- 9.4.2. Europe: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
- 9.4.3. Europe: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
- 9.4.4. Europe: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.5. Soft Tissue Sarcoma Treatment Market - UK
  - 9.4.5.1. UK: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.4.5.2. UK: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.4.5.3. UK: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.4.5.4. UK: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.6. Soft Tissue Sarcoma Treatment Market - France
  - 9.4.6.1. France: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.4.6.2. France: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.4.6.3. France: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.4.6.4. France: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.7. Soft Tissue Sarcoma Treatment Market - Germany
  - 9.4.7.1. Germany: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.4.7.2. Germany: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.4.7.3. Germany: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.4.7.4. Germany: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.8. Soft Tissue Sarcoma Treatment Market - Italy
  - 9.4.8.1. Italy: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.4.8.2. Italy: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.4.8.3. Italy: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.4.8.4. Italy: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.9. Soft Tissue Sarcoma Treatment Market - Spain
  - 9.4.9.1. Spain: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.4.9.2. Spain: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.4.9.3. Spain: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.4.9.4. Spain: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.10. Soft Tissue Sarcoma Treatment Market - Netherlands
  - 9.4.10.1. Netherlands: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.4.10.2. Netherlands: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.4.10.3. Netherlands: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.4.10.4. Netherlands: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.11. Soft Tissue Sarcoma Treatment Market - Russia
  - 9.4.11.1. Russia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.4.11.2. Russia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.4.11.3. Russia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.4.11.4. Russia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.12. Soft Tissue Sarcoma Treatment Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
9.5. Soft Tissue Sarcoma Treatment Market - Asia Pacific
- 9.5.1. Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.5. Soft Tissue Sarcoma Treatment Market - China
  - 9.5.5.1. China: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.5.5.2. China: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.5.5.3. China: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.5.5.4. China: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.6. Soft Tissue Sarcoma Treatment Market - India
  - 9.5.6.1. India: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.5.6.2. India: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.5.6.3. India: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.5.6.4. India: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.7. Soft Tissue Sarcoma Treatment Market - Malaysia
  - 9.5.7.1. Malaysia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.5.7.2. Malaysia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.5.7.3. Malaysia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.5.7.4. Malaysia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.8. Soft Tissue Sarcoma Treatment Market - Japan
  - 9.5.8.1. Japan: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.5.8.2. Japan: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.5.8.3. Japan: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.5.8.4. Japan: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.9. Soft Tissue Sarcoma Treatment Market - Indonesia
  - 9.5.9.1. Indonesia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.5.9.2. Indonesia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.5.9.3. Indonesia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.5.9.4. Indonesia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.10. Soft Tissue Sarcoma Treatment Market - South Korea
  - 9.5.10.1. South Korea: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.5.10.2. South Korea: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.5.10.3. South Korea: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.5.10.4. South Korea: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.11. Soft Tissue Sarcoma Treatment Market - Australia
  - 9.5.11.1. Australia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.5.11.2. Australia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.5.11.3. Australia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.5.11.4. Australia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.12. Soft Tissue Sarcoma Treatment Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
9.6. Soft Tissue Sarcoma Treatment Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.5. Soft Tissue Sarcoma Treatment Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.6. Soft Tissue Sarcoma Treatment Market - UAE
  - 9.6.6.1. UAE: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.6.6.2. UAE: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.6.6.3. UAE: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.6.6.4. UAE: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.7. Soft Tissue Sarcoma Treatment Market - Israel
  - 9.6.7.1. Israel: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.6.7.2. Israel: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.6.7.3. Israel: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.6.7.4. Israel: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.8. Soft Tissue Sarcoma Treatment Market - South Africa
  - 9.6.8.1. South Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.6.8.2. South Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.6.8.3. South Africa: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.6.8.4. South Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.9. Soft Tissue Sarcoma Treatment Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
9.7. Soft Tissue Sarcoma Treatment Market - Latin America
- 9.7.1. Latin America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
- 9.7.2. Latin America: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
- 9.7.3. Latin America: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
- 9.7.4. Latin America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.5. Soft Tissue Sarcoma Treatment Market - Mexico
  - 9.7.5.1. Mexico: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.7.5.2. Mexico: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.7.5.3. Mexico: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.7.5.4. Mexico: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.6. Soft Tissue Sarcoma Treatment Market - Brazil
  - 9.7.6.1. Brazil: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.7.6.2. Brazil: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.7.6.3. Brazil: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.7.6.4. Brazil: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.7. Soft Tissue Sarcoma Treatment Market - Argentina
  - 9.7.7.1. Argentina: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.7.7.2. Argentina: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.7.7.3. Argentina: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.7.7.4. Argentina: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.8. Soft Tissue Sarcoma Treatment Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2020-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: Soft Tissue Sarcoma Treatment Market, by Indication, 2020-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: Soft Tissue Sarcoma Treatment Market, by End-Use, 2020-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Amgen Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. AstraZeneca plc
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Bayer AG
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Bristol-Myers Squibb Company
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Celgene Corporation
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Eli Lilly and Company
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. F. Hoffmann-La Roche AG
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. GlaxoSmithKline plc
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Johnson & Johnson Services, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Merck & Co., Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development

軟部肉腫治療の世界市場：市場規模・シェア・動向、業界分析 (治療法別・適応症別・流通チャネル別・最終用途別・地域別)、将来予測 (2025年～2034年)

Soft Tissue Sarcoma Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment, Indication, Distribution Channel, End Use, and Region - Market Forecast, 2025-2034

軟部肉腫治療市場：分析概要

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章世界の軟部肉腫治療市場の洞察

第5章世界の軟部肉腫治療市場：治療法別

第6章世界の軟部肉腫治療市場：適応症別

第7章世界の軟部肉腫治療市場：最終用途別

第8章世界の軟部肉腫治療市場：流通チャネル別

第9章世界の軟部肉腫治療市場：地域別

第10章競合情勢

第11章企業プロファイル

List of Tables:

List of Figures:

Soft Tissue Sarcoma Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Soft Tissue Sarcoma Treatment Market Insights

5. Global Soft Tissue Sarcoma Treatment Market, by Treatment

6. Global Soft Tissue Sarcoma Treatment Market, by Indication

7. Global Soft Tissue Sarcoma Treatment Market, by End-Use

8. Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel

9. Global Soft Tissue Sarcoma Treatment Market, by Geography

10. Competitive Landscape

11. Company Profiles

軟部肉腫治療の世界市場：市場規模・シェア・動向、業界分析 (治療法別・適応症別・流通チャネル別・最終用途別・地域別)、将来予測 (2025年～2034年)

Soft Tissue Sarcoma Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment, Indication, Distribution Channel, End Use, and Region - Market Forecast, 2025-2034

軟部肉腫治療市場：分析概要

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界の軟部肉腫治療市場の洞察

第5章 世界の軟部肉腫治療市場：治療法別

第6章 世界の軟部肉腫治療市場：適応症別

第7章 世界の軟部肉腫治療市場：最終用途別

第8章 世界の軟部肉腫治療市場：流通チャネル別

第9章 世界の軟部肉腫治療市場：地域別

第10章 競合情勢

第11章 企業プロファイル

List of Tables:

List of Figures:

Soft Tissue Sarcoma Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Soft Tissue Sarcoma Treatment Market Insights

5. Global Soft Tissue Sarcoma Treatment Market, by Treatment

6. Global Soft Tissue Sarcoma Treatment Market, by Indication

7. Global Soft Tissue Sarcoma Treatment Market, by End-Use

8. Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel

9. Global Soft Tissue Sarcoma Treatment Market, by Geography

10. Competitive Landscape

11. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章世界の軟部肉腫治療市場の洞察

第5章世界の軟部肉腫治療市場：治療法別

第6章世界の軟部肉腫治療市場：適応症別

第7章世界の軟部肉腫治療市場：最終用途別

第8章世界の軟部肉腫治療市場：流通チャネル別

第9章世界の軟部肉腫治療市場：地域別

第10章競合情勢

第11章企業プロファイル